Molecular Partners Ag (MOLN) Cash & Current Investments (2020 - 2026)
Molecular Partners Ag (MOLN) recorded Cash & Current Investments of $75.78 million in Q2 2026, up 47.8% from $51.27 million a year earlier and up 5.6% from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Molecular Partners Ag reported Cash & Current Investments of $112.29 million, down 33.9% from FY2024.
- Annual Cash & Current Investments has declined for three straight years, with a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $169.82 million in FY2024 (-18.4%), $208.1 million in FY2023 (-20.3%), $261.13 million in FY2022 (+79.7%) and $145.33 million in FY2021 (-21.5%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q1 2022.
- Per Business Quant, the preceding three quarters came in at $71.79 million (Q1 2026), $20.49 million (Q4 2025) and $33.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Molecular Partners Ag | 150.19 Mn | -281.05 Mn | - | 84.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.11 Mn |
| Mar 31, 2026 | 98.47 Mn |
| Dec 31, 2025 | 117.54 Mn |
| Sep 30, 2025 | 131.11 Mn |
| Jun 30, 2025 | 143.42 Mn |
| Mar 31, 2025 | 148.61 Mn |
| Dec 31, 2024 | 165.45 Mn |
| Sep 30, 2024 | 170.87 Mn |
| Jun 30, 2024 | 175.29 Mn |
| Mar 31, 2024 | 193.25 Mn |
| Dec 31, 2023 | 221.60 Mn |
| Sep 30, 2023 | 225.88 Mn |
| Jun 30, 2023 | 242.67 Mn |
| Mar 31, 2023 | 254.41 Mn |
| Dec 31, 2022 | 269.97 Mn |
| Sep 30, 2022 | 274.00 Mn |
| Jun 30, 2022 | 120.46 Mn |
| Mar 31, 2022 | 320.97 Mn |
| Dec 31, 2021 | 145.36 Mn |
| Sep 30, 2021 | 165.11 Mn |
API Access
Molecular Partners Ag Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();